Company Description
Rigaku Raman Technologies is leading with innovation to pioneer a portfolio of handheld and portable Raman instruments tailored to support the protection of public health and safety while aiding the advancement of scientific research and academic study. We are proud to be setting new benchmarks in spectroscopy by providing advanced analytical solutions that enable customers to achieve rapid lab-quality results any time, any place.
Company Background
Since its inception in 1951, Rigaku has built upon its experience to develop innovative and fully integrated solutions with hundreds of major innovations to their credit. Rigaku Raman Technologies continues this tradition by delivering customizable Raman analyzers designed to provide enhanced application specific solutions for it’s customers. Rigaku employs over 1,100 valued people worldwide in operations based in Japan, U.S., Europe and China with distribution networks worldwide. Close collaboration between our users and employees sets the direction and focus of our work, allowing us to address customers’ needs and stay close to the market place.
Markets Served
Rigaku Raman Technologies provides GMP ready handheld and truly portable Raman instruments to pharmaceutical, biopharmaceutical and chemical manufacturers for material verification and finished product authentication to ensure product quality and consumer safety. Our instruments also serve the changing needs of life science and academic laboratories by enabling a modern and collaborative approach to scientific research, analysis and integrated lab-lecture learning environments..
Products, Services & Capabilities
What was once a lab-based technology now powers the first product line of customizable, handheld and portable Raman analyzer’s developed by Rigaku Raman Technologies. With the handheld FirstGuard™ and Xantus-2™ – the first portable dual wavelength instrument in the industry- Rigaku Raman takes the handheld trend a step further to provide tailored Raman solutions with multiple laser excitation options at 532nm, 785nm and/or 1064nm. The use of 1064nm can minimize and often eliminate fluorescence issues for most sample types, providing broader compound coverage and actionable results. 21 CFR Part 11 compliant, our products utilize integrated software that combines an open architecture platform with customizable, user defined settings for optimized sampling parameters enabling unparalleled accuracy and extensive application support.
www.americanpharmaceuticalreview.com | | 23
www.rigakuraman.com/solutions
Rigaku Raman Technologies, Inc. 14 New England Executive Park, Suite 102 Burlington, MA 01803 USA Tel: +1 855-785-1064
RIGAKU RAMAN TECHNOLOGIES, INC.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156